$ASBP Up 49% Premarket! 🚀 🔹 Aspire Biopharma is developing patent-pending drug delivery technology focused on fast-acting formulations 🔹 Recent catalyst watc

$ASBP Up 49% Premarket! 🚀 🔹 Aspire Biopharma is developing patent-pending drug delivery technology focused on fast-acting formulations 🔹 Recent catalyst watch: newly Nasdaq-listed after completing its business combination with PowerUp Acquisition Corp. 👀 🔹 Company also recently announced a 1-fo…